Cpap

Origin and history

The concept of continuous positive airway pressure (CPAP) therapy for sleep apnea originated in Australia in the early 1980s. Dr. Colin Sullivan and his team at the Royal Prince Alfred Hospital in Sydney developed the first practical device. Their work was built upon earlier physiological research into positive pressure ventilation used in hospital intensive care settings. The initial prototype was constructed using a vacuum cleaner motor adapted to generate positive airflow. Clinical trials demonstrated a dramatic reversal of obstructive sleep apnea symptoms during sleep. This pioneering work established the foundational technology for all subsequent CPAP machines. The treatment gained formal medical acceptance and began to be manufactured commercially by the mid-1980s.

What it is for

CPAP therapy is primarily prescribed for the treatment of obstructive sleep apnea (OSA). It is designed to prevent the collapse of the upper airway that occurs during sleep in individuals with this condition. The continuous stream of pressurized air acts as a pneumatic splint, holding the throat open. This prevents the apneas (complete breathing pauses) and hypopneas (shallow breaths) that characterize the disorder. By maintaining an open airway, the therapy eliminates the frequent sleep disruptions caused by breathing struggles. Consequently, it restores normal sleep architecture and prevents the associated drops in blood oxygen levels. The treatment is also used for certain cases of central sleep apnea and other forms of sleep-disordered breathing where positive airway pressure is indicated.

Pros and cons

A primary advantage of CPAP therapy is its high efficacy in eliminating sleep apnea events when used consistently, which can lead to immediate improvements in sleep quality and daytime alertness. It is a non-invasive alternative to surgical interventions and does not require permanent anatomical changes. However, a significant con is that many users struggle with initial acclimatization to sleeping with a mask and the sensation of pressurized air. Common complaints include nasal congestion, dry mouth, skin irritation from the mask seal, and claustrophobia. The most frequent mistake is abandoning the therapy during the difficult first few weeks without seeking adjustments from a healthcare provider. Users often regret choosing a mask style based on aesthetics rather than fit, leading to air leaks and discomfort that undermine compliance. The necessity for nightly use and the reliance on electricity and equipment for travel are also considered drawbacks by some individuals.

Who it suits

CPAP therapy is most suited for individuals with a confirmed diagnosis of moderate to severe obstructive sleep apnea, where the benefits strongly outweigh the burdens of treatment. It is often the first-line treatment for these patients. It suits individuals who are motivated to use the device consistently every night, as benefits are entirely dependent on regular use. The therapy can be adapted for a wide range of patients through various mask types (nasal, nasal pillow, full-face) and machines with comfort features like pressure ramping or humidification. It is particularly important for patients with significant cardiovascular comorbidities linked to sleep apnea, such as hypertension or atrial fibrillation. CPAP is generally not suited for individuals with untreated nasal obstructions, active ear or sinus infections, or those who experience recurrent episodes of aerophagia (swallowing air) that cannot be managed with pressure adjustments.